0.9% saline ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	1
70	Spinal stenosis	1

6. Parkinson disease

---

Clinical trials : 2,298 /  Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05197439 (ClinicalTrials.gov)	April 1, 2022	5/1/2022	Dexmedetomidine Prevents Postoperative Delirium After Deep Brain Stimulation in Patients With Parkinson's Disease	Effect of Dexmedetomidine on Postoperative Delirium in Elderly Patients With Parkinson's Disease Undergoing Deep Brain Stimulation: a Randomized Controlled Trial	Dexmedetomidine;Postoperative Delirium;Deep Brain Stimulation	Drug: Dexmedetomidine;Drug: 0.9% saline	Beijing Tiantan Hospital	NULL	Not yet recruiting	60 Years	N/A	All	182	N/A	China

70. Spinal stenosis

---

Clinical trials : 96 /  Drugs : 203 - (DrugBank : 60) / Drug target genes : 66 - Drug target pathways : 89

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00808665 (ClinicalTrials.gov)	June 2009	15/12/2008	Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion	Does Continuous Perioperative Dexmedetomidine Infusion Reduce Time to Discharge in Patients Undergoing Major Lumbar Fusion? A Double-Blind, Placebo-Controlled Study	Spinal Fusion Acquired;Spinal Stenosis;Lesions of Lumbosacral Intervertebral Disc;Spinal Diseases	Drug: Dexmedetomidine;Drug: 0.9% Saline	Vanderbilt University Medical Center	NULL	Completed	18 Years	85 Years	All	68	Phase 4	United States